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Triton X-114Human phospholipid scramblase 1 (SCR) consists of a large cytoplasmic domain and a small presumed trans-
membrane domain near the C-terminal end of the protein. Previous studies with the SCRΔmutant lacking the
C-terminal portion (last 28 aa) revealed the importance of this C-terminal moiety for protein function and
calcium-binding afﬁnity. The present contribution is intended to elucidate the effect of the transmembrane do-
main suppression on SCRΔ binding to model membranes (lipid monolayers and bilayers) and on SCRΔ reconsti-
tution in proteoliposomes. In all cases the protein cytoplasmic domain showed a great afﬁnity for lipid
membranes, and behaved in most aspects as an intrinsic membrane protein. Assays have been performed in
the presence of phosphatidylserine, presumably important for the SCR cytoplasmic domain to be electrostatically
anchored to the plasma membrane inner surface. The fusion protein maltose binding protein-SCR has also been
studied as an intermediate case of a molecule that can insert into the bilayer hydrophobic core, yet it is stable in
detergent-free buffers. Although the intracellular location of SCR has been the object of debate, the present data
support the viewof SCR as an integralmembrane protein, inwhich not only the transmembrane domain but also
the cytoplasmic moiety play a role in membrane docking of the protein.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Human phospholipid scramblase 1 (SCR) is an endofacial, calcium-
dependent monotopic membrane protein, which is associated to lipid
rafts when multipalmitoylated [1,2]. SCR is a member of a family
of membrane proteins that has been proposed to catalyze the
Ca2+-dependent, ATP-independent transbilayer lipid motion, or ﬂip-
ﬂop, thus leading to the loss of membrane lipid asymmetry [1,2]. SCR
has a broadly globular structure with a hydrophobic stretch near the
C-end (residues 291–309) that is presumed to act as a transmembrane
domain (TMD) that would anchor the protein to the membrane. Previ-
ous work from this laboratory with SCRΔ, the human phospholipid
scramblase 1 (SCR) mutant lacking the C-terminal 28 aa, supports the
hypothesis of the presence in the protein of a TMD in the C-terminal
end, as a determinant for the lipid “scrambling” and calcium binding
activities [3], in agreement with the observations by Francis et al. [4].
The TMD is close to the calcium-binding domain in the protein, maltose binding protein; OG,
erine; SCR, human phospholipid
tant [1M-K290]; TMD, transmem-sequence, and both could be mutually regulated. Calcium binds
both the wild type and mutant proteins but the lack of TMD decreases
the calcium-binding afﬁnity of SCRΔ by about 5–10 fold and affects
protein folding and stability. Peptides representing the presumed
TMD have been shown to become inserted in lipid bilayers of different
compositions [5].
It has been reported [6] that SCRΔ, when expressed in Jurkat cells, is
no longer localized preferentially in the plasma membrane, but rather
distributed evenly in the cytosol. However the precise intracellular
location and even the function of SCR have been disputed. When SCR
is palmitoylated it partitions with EGF receptor in lipid rafts [1]. In the
absence of palmitoylation, virtually all of the expressed SCR localizes
to the nucleus [2] where the protein binds a genomic DNA with high
afﬁnity suggesting a potential function as a transcription factor [7,8].
These data suggest that the post-translational acylation determines
the protein localization in the cell and regulates its normal function,
either in the nucleus or incorporated to the membrane [2,9].
A subsequent structural model computed by homology modeling
suggests that the C-terminal transmembrane helix is buried within the
SCR core and that palmitoylation may represent the principal
membrane anchorage for the protein [10]. Other studies reveal that
SCR is secreted via a lipid-raft dependent mechanism and deposited in
the extracellularmatrix, suggesting that SCR is amultifunctional protein
that can function both inside and outside of the cell. In addition, the
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the trafﬁcking and secretion of SCR [11].
In our previous study [3]we found that SCRΔ in thepresence of Ca2+
could not promote lipid translocation, at variance with the wild-type,
thus suggesting that the TMD was important both for Ca2+ binding
and for the protein overall active conformation. In the present study
we intend to show that the truncated form in the absence of Ca2+
shares many similarities with the wild-type protein in its interaction
with membranes. We have clariﬁed the effect of TMD suppression on
protein binding to model membranes made of egg PC or PC:PS
(9:1mol ratio) (the lattermimicking the cellmembrane innermonolay-
er).We have also analyzed the reconstitution process behavior of SCRΔ.
Demonstrating that the truncated SCRA can still bind to lipid bilayers is
important because there is still some debate about the cell location and
in vivo function of SCR [4,10,11]. Our SCRΔ preparation, expressed in
Escherichia coli, is not palmitoylated thus it is less likely to interact
with membranes than the corresponding domain expressed in eukary-
otic cells. Even so the results demonstrate that the SCR cytoplasmic do-
main features ﬂexible and adaptive interactions with the surrounding
membrane, behaving in crucial aspects like an intrinsic membrane pro-
tein. A parallel study of the fusion protein maltose binding protein
(MBP)-SCR describes an intermediate case of an artiﬁcial form of the
protein that can bind thehydrophobicmembrane core, yet it can remain
stable in solution in the absence of detergents.
2. Materials and methods
2.1. Materials
Egg phosphatidylcholine (PC) and spinal cord phosphatidylserine
(PS) were purchased from Avanti Polar Lipids (Alabaster, AL) and
Lipid Products (South Nutﬁeld, UK), respectively. The monoclonal
anti-scramblase antibody was from Abcam (Cambridge, UK) and HRP-
linked anti-mouse antibody was from New England Biolabs (MA,
USA). D2O was from Apollo scientiﬁc (Cheshire, UK). Octylglucoside
was from Calbiochem (USA). Triton X-114 was from Sigma (MO,
USA). All other reagents were of analytical grade.
2.2. Protein puriﬁcation
SCRΔ puriﬁcation was achieved by extracting the protein from
inclusion bodies [3]. Brieﬂy, SCRΔ was expressed in E. coli BL21-Codon
Plus and protein over-expression was induced with 1 mM IPTG for 12
h at 16 °C. Cells were harvested by centrifugation and resuspended in
“lysis buffer” (200 mM NaCl, 1 mM DTT, 1 mM EDTA, 20 mM Tris,
pH 7.5) and treated with lysozyme. The samples were then sonicated,
the suspensions centrifuged, and the inclusion bodies recovered in the
pellet. After several washing steps, the pellets were resuspended in
“TU buffer” (6 M urea, 50 mM NaCl, 0.1 mM TCEP, 20 mM Tris,
pH 7.5) and centrifuged to collect the soluble fraction. The sample in
TU buffer was then applied to a HisTrap HP column and the protein
was eluted in a stepwise 0 to 500 mM imidazole gradient in the same
TU buffer. Finally, the protein underwent overnight dialysis in order to
remove the urea.
MBP–SCRwas expressed in E. coli BL21 Codon plus strain. The fusion
proteinwasﬁrst puriﬁed using an amylose resin and then diluted 5-fold
with “T-A buffer” (1 mM DTT, 20 mM Tris, pH 7.5) and applied to a
DEAE–Sepharose ion exchange column. Finally the protein was eluted
in a stepwise 0 to 150 mM NaCl gradient in the same buffer. MBP–SCR
was not subjected to cleavage with Factor Xa.
2.3. Surface pressure measurements
Lateral pressure experiments were carried out in a multi-well Delta
Pi-4 Langmuir balance (Kibron Inc., Helsinki, Finland) under constant
stirring. SCR- and SCRΔ-induced changes in surface pressure at theair–water interface and protein–lipid monolayer interactions were
studied at 25 °C. Monolayers were formed by spreading a small amount
of the lipid mixtures in chloroform:methanol (2:1 v/v) solution on top
of assay buffer, until the desired initial surface pressure was reached.
Proteins were injected with a micropipette through a hole connected
to the subphase with constant stirring. The assay buffer was 50 mM
NaCl, 20 mM Tris, pH 7.4.
2.4. SCR and SCRΔ binding to LUVs
PC:PS (9:1 mol:mol) LUVs, corresponding to 1 μmol lipidwere dilut-
ed to 1 ml D2O buffer (100 mM KCl, 0.1 mM EGTA, 20 mM Tris, pH 7.4)
together with the appropriate amount of protein, to give a protein:lipid
molar ratio of 1:1000. Themixturewas allowed to equilibrate for 30min
at room temperature, and then centrifuged in a 120.2 Beckman rotor
(500,000 ×g, 2 h, 20 °C) [12]. In this fashion the free, but not the lipid-
bound protein will sediment when centrifuged. 100 μl were recovered
and assayed for lipid and protein quantiﬁcations by phosphorous and
dot blot, respectively. Brieﬂy, dot blots for protein quantiﬁcation were
performed using a Hybond-C extra (Amersham Biosciences) mem-
brane. The D2O gradient-derived samples were spotted onto the mem-
brane and blocked with 5% skim milk for 1 h at room temperature,
followed by 1 h incubation at room temperature with anti-scramblase
antibody (1:1000). The blot was washed several times with PBS,
pH 7.4, and incubated for 1 h with an HRP-linked anti-mouse antibody
(1:2000). After ﬁnal washings to eliminate the unbound secondary an-
tibody, the blot was developed on a Curix 60 processor (AGFA, Belgium)
using Amersham Hyperﬁlm ECL (GE Healthcare, UK). The intensity
of the sample signal was measured with a GS-800 densitometer (Bio-
Rad, Stockholm, Sweden).
2.5. SCR and SCRΔ reconstitution analysis
Either SCRΔ or MBP–SCR proteins were incubated with LUVs (at a
1:800 protein-to-lipid mol ratio) in 100 mM KCl, 0.1 mM EGTA,
100 mM Tris, pH 7.5, in the presence of saturating concentrations of
octyl-β-glucopyranoside (27–34mM) for 1 h followed by overnight di-
alysis in the presence of SLM-Aminco BioBeads (2 g/l). The recovered
sampleswere next dialyzed against D2O buffer in Slide-A-LyzerMini Di-
alysis units. Sampleswere then ultracentrifuged in a TLA 120.2 Beckman
rotor at 500,000 ×g for 2 h at 20 °C. The various gradient fractions were
recovered in 100 μl aliquots. The polycarbonate centrifuge tubes were
then washed with 100 μl hot 1% (w/v) SDS to recover protein that had
been aggregated or adhered to the tube walls.
2.6. Solubilization by Triton X-114
The upper two fractions recovered from the isolated reconstituted
D2O proteoliposomes of MBP–SCR or mutant SCR were dissolved in
1% (w/v) Triton X-114 at 4 °C. Then, the sample was heated up to the
detergent cloud point, at 30 °C for 10 min, and centrifuged at low
speed (1000 ×g, 3 min, 30 °C) to facilitate phase separation [13–15].
Aliquots from the upper (detergent poor) and lower (detergent rich)
phases were subjected to dot blotting. A non-reconstituted protein
(control sample) was subjected to the same procedure.
3. Results
3.1. Langmuir balance studies: protein adsorption at the air–water
interface
SCRΔ tendency to self-aggregate strongly suggests that the protein is
a surface-active molecule. This is conﬁrmed by its behavior in the
Langmuir balance. Langmuir balance approaches are based on themea-
surement of the water surface tension by means of a suspended solid
probe (the Wilhelmy plate) that is slightly introduced into the air–
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rapid, dose dependent increase of lateral pressure π at the air–water in-
terface. π is usually measured in nN/m. An increase in π is an indication
that the protein is adsorbing onto the air–water interface. Time courses
of interface adsorption of SCRΔ at different concentrations can be seen
in Fig. 1A. A discontinuity in the π vs. time plots was observed for all
SCRΔ concentrations, that could be attributed to a small change in
protein conformation, but the phenomenon was not further explored.
Fig. 1C–D summarizes the change in Δπ as a function of SCRΔ and
MBP–SCR protein concentrations, respectively. For the mutant protein,
the increase in surface pressure appears to reach a plateau value of
~24 mN/m at 100 nM concentration. For the MBP–SCR fusion protein
the increase in surface pressure is lower than in the case of SCRΔ, with
a plateau value of ~15 mN/m (at 25–50 nM), presumably due to the
stabilizing effect of the bound MBP.
SCR cannot be separated fromMBP as a result of its high hydropho-
bicity and instability in the absence of detergents. Pure MBP gave a
signal of incorporation to the air–water interface (Fig. 1B), but it was0 20 40 60 80 100 120
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Fig. 1. Langmuir balance measurements at the air–water interface. (A, B) Time course of
adsorption of SCRΔ (A) and MBP–SCR (black) and MBP (grey) (B) at the air–water inter-
face. On (C, D) the maximum increase in lateral pressure caused by SCRΔ (C) and MBP–
SCR (D) adsorption at the air–water interface is shown. The change in lateral pressure is
plotted as a function of initial protein concentration injected to the subphase.found later that it did not interact with lipid monolayers (see below).
Hence, surface pressure changes when working with lipid monolayers
are due to the SCR moiety, without any signal component arising from
MBP.3.2. Langmuir balance studies: protein insertion into lipid monolayers
When a monomolecular ﬁlm of phospholipid is spread at the lipid–
water interface, once equilibrium is reached an initial lateral pressure
πi is measured for the lipid monolayer. Protein insertion into themono-
layer will increase the lateral pressure by Δπ. SCRΔ (400 nM injected to
the subphase)was able to insert into lipidmonolayers of PC extended at
the air–water interface (Fig. 2A). The same trend was observed for
MBP–SCR (100 nM injected to the subphase) (Fig. 2B). However MBP
alone did not become inserted into the lipid monolayer (Fig. 2B).
Fig. 3 shows the change in lateral pressure as a function ofmonolayer
initial pressure, for SCRΔ inserted in PC and PC:PS monolayers (Fig. 3A)
and for MBP–SCR inserted in PC and PC:PS monolayers (Fig. 3B). The
protein insertion-dependent change in lateral pressure (Δπ) decreases
linearly for both proteins with the increase in initial pressure (πi). In
the case of MBP–SCR (Fig. 3B) the presence of PS does not clearlymodify
the protein interaction with the lipid monolayer. On the contrary for
SCRΔ (Fig. 3A) PS affects protein insertion, decreasing somewhat the
protein capacity to interact with the monolayer.
Above a certain πi value (termed critical pressure or πc) no more
protein insertion is observed. πc can be calculated by extrapolating the
Δπ vs. πi line to Δπ= 0. In the case of SCRΔ (Fig. 3A), the obtained πc
values are within the accepted average value of 30 mN/m ± 5 mN/m
for the lateral pressure of cell membranes [16–18]. The πc calculated
values for MBP–SCR (Fig. 3B) are at the lower limit of membrane inser-
tion, probably due to the stabilizing effect of MBP on protein structure,
which could decrease its afﬁnity for lipids (see Table 1). In general the
data suggest that SCRΔ could insert into model or cell membranes.0 100 200 300 400 500
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Fig. 2. Time course of adsorption of SCRΔ (A), andMBP–SCR (black) andMBP (grey) (B) at
the PC–water interface. The arrow indicates the time of protein addition to the subphase.
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Fig. 3.Maximum increase in lateral pressure after SCRΔ (A) andMBP–SCR (B) insertion in lipid monolayers. The appropriate lipids were spread as a monomolecular ﬁlm at the air–water
interface, at a lateral pressure πi. Then proteins were injected into the subphase and the increase in lateral pressureΔπwas recorded. Lipids were: [●] PC, [▲] PC:PS (9:1 mol ratio). Data
reported as a function of initial lateral pressure.
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The basis of the centrifugation method for measuring SCRΔ and
MBP–SCR proteins binding to LUV is shown in Figs. 4 and 5, respectively.
When either vesicles or protein are independently centrifuged in D2O
buffer, the lipid remains on top of the tube while all of the protein sed-
iments at the tube bottom. Butwhen LUVs and protein are incubated to-
gether and the mixture centrifuged, a substantial part of the protein
remains in the top part of the tube, i.e. vesicle-bound [12].
Figs. 4A and 5A display the dot blots developed for this test for each
protein (SCRΔ and MBP–SCR, respectively) and show that a protein
fraction could always be extracted from the tube wall irrespective of
the presence of vesicles. However, in all cases the proteins incubated
with LUVs remained partly in solution, presumably associated to the
vesicle membrane.
In the case of SCRΔ (Fig. 4) the protein is seen to bind LUVs, as com-
pared to the pure proteinwhich, in the absence of vesicles, sediments at
the tube bottom. In the case ofMBP–SCR (Fig. 5) protein binding to LUVs
is similar to that observed for SCRΔ (protein:lipid ratios indicated in the
corresponding ﬁgure legends). In none of these cases protein binding
led to vesicle aggregation or vesicle content efﬂux (data not shown).
3.4. Analysis of the reconstitution proﬁle
In a further effort to characterize the nature of the interaction of SCR
cytoplasmic domain (SCRΔ) with lipid bilayers, we attempted the solu-
bilization and phase separation in Triton X-114 of free and membrane-
bound proteins, the latter having been previously reconstituted in LUVs.
Proteoliposomes were isolated from the non-bound protein by D2O
ultracentrifugation (Fig. 6) and the 2 upper aliquots (numbered 1 and
2) were combined for the solubilization assay. Note that the lipid-
protein ratios of the reconstituted proteoliposomes were lower than
those measured directly on the lipid-protein mixtures (Figs. 4 and 5).
The detergent Triton X-114 forms a homogeneous phase at 4 °C, but
separates into detergent-poor and detergent-rich phases above 20 °C
[13]. Proteins solubilized at 4 °C can therefore be separated by rising
the temperature: the hydrophilic proteins or proteins which do notTable 1
Critical pressures (πc) for SCRΔ and MBP–SCR insertion in monolayers. Data calculated
from the graphics in Fig. 3. The tendency line associated standard error is given for eachπc.
Protein PC PC:PS 9:1 (mol:mol)
SCRΔ 30.4 mN/m (±0.31) 26.2 mN/m(±0.22)
MBP–SCR 24.4 mN/m (±0.28) 25.1 mN/m(±0.22)strongly interact with the vesicles are found exclusively in the
detergent-poor phase, whereas integral membrane proteins with a
strong amphipathic nature are recovered in the detergent-rich phase.
SCRΔ and MBP–SCR, either free or reconstituted, were solubilized in
1% TX-114 (4 °C) and then incubated at 30 °C, subsequent detergent
phase separation being helped by low-speed centrifugation. Aliquots
of detergent-rich and detergent-poor fractions were analyzed by dot
blot (Fig. 7), and the corresponding controls (pure proteins, no LUVs)
were included for a direct comparison.
In the absence of lipids, the proteins appeared both in the detergent-
poor (upper) and detergent-rich (lower) phases (Fig. 7A–C) probably
due to their amphipathic nature. However, when proteins were
previously reconstituted in PC:PS (9:1) LUVs, in both cases the
detergent-poor phase was virtually devoid of protein, which was only
found in the detergent-rich phase (Fig. 7B for SCRΔ and 7D for MBP–
SCR), thus conﬁrming that the protein cytoplasmic portion, even in
the absence of the protein TMD, interacts strongly with lipids, a behav-
ior that reminds that of intrinsic proteins.4. Discussion
The present study focuses on a truncated form of SCR, consisting of
the protein cytoplasmic portion. It was previously seen [3,4] that
removal of the TMD domain totally inhibited its activity as a lipid ﬂip-
ﬂop catalyst, perhaps by virtue of the decreased calcium-afﬁnity
constant (5-fold). Here we intended to analyze the TMD suppression
impact on the protein lipid afﬁnity (mono- and bilayers).
It should be noted that the proteins used in this study have been
expressed in E. coli, thus they do not contain the post-translational
modiﬁcations, mainly palmitoylation, that are known to occur in mam-
malian cells. However the absence of acylation does not abolish the
scramblase activity [3,4,21], suggesting that the lack of acyl residues
does not lead to major changes in the protein structure/function.
Moreover Merregaert et al. [11] observed that native SCR expressed in
HaCaT cells in the presence of 2-bromopalmitate, thus in the absence
of acylation, is localized to the plasma membrane and secreted to the
extracellular medium. These authors conclude that acylation is not
involved in intracellular membrane trafﬁc. An additional factor to be
considered when interpreting the above results is that the C-terminal
domain of SCRΔmay be incorrectly folded, allowing the exposure of hy-
drophobic patches to the aqueous medium. However, according to ANS
binding experiments [3] this appears to occur to a moderate extent. In
general the available data support the validity of our observations
with E. coli-expressed SCRΔ.
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Fig. 1A–C shows the adsorption of SCRΔ at the air–water interface,
demonstrating the surface-active nature of this protein fragment.
Monolayer studies have been extensively used in the study of puriﬁed
membrane proteins interacting with lipid layers [16–18], and this was
also performedwith the truncated SCR. By spreading pure PC or PCmix-
tures with PS (9:1 mol:mol) the afﬁnity for lipids was analyzed. SCRΔ
may become inserted into monolayers at an initial π0 in the range 26–
30 mN/m (Fig. 3A). This is important because cell membranes are con-
sidered to support a lateral pressure π ≈ 30 mN/m [16], albeit with
large ﬂuctuations around this average value (±5 mN/m). Although
the lateral pressures obtained for the mutant membrane protein are
below those found for other proteins in the Langmuir balance, e.g.
the toxins equinatoxin II (πc ~ 50 mN/m) [19] or E. coli α-hemolysin
(πc ~ 35 mN/m) [20], the data in Fig. 3 indicate that SCRΔ can insert
into model or cell membranes, demonstrating the surface-active nature
of the scramblase cytoplasmic domain.
4.2. SCRΔ binds vesicles
The data on protein interactionwith LUV (Figs. 4 and 5) demonstrate
that both proteinsMBP–SCR and SCRΔ bind lipid bilayers. Note however
that both proteins are differently puriﬁed: SCRΔ is more stable in buffer
in the absence of the TMDas compared to native SCR, and can be obtain-
ed at low concentrations in the absence of aggregation. For thewild type
it is not possible to separate the SCR portion from its partner (MBP)unless when reconstituted or in the presence of detergent. TheMBP sta-
bilizing effect is clear (Fig. 5): the wild type protein binding to LUVs
might be weaker than SCRΔ binding to LUVs, since MBP allows SCR sta-
bility in solution thus SCR does not require LUVs binding for stability. On
the contrary, the SCRΔ amphipathic nature is remarkable, and the ab-
sence of TMD does not hinder the protein strong binding to LUVs
(Fig. 4).
4.3. SCRΔ behaves as an intrinsic protein
MBP–SCR and SCRΔ were subjected to the same reconstitution
process. The fraction patterns isolated from the D2O ultracentrifugation
were very similar (Fig. 6), as compared with the pure non-
reconstituted proteins. Nevertheless, SCRΔ could be either just adsorbed
or strongly bound to the vesicle surface (Fig. 4), so an additional test was
performed, to clarify the mutant precise interaction with LUVs.
TX-114 has been shown to solubilize membranes, allowing a clear
phase separation, leaving the soluble and the extrinsic membrane pro-
teins in the detergent-poor phase, and with the detergent-rich phase
containing the integral membrane proteins [13–15]. The latter is the
way in which both proteins, MBP–SCR and the TMD-lacking mutant,
behave (Fig. 7).
4.4. The properties of MBP–SCR
The instability of intrinsic and other strongly membrane-bound pro-
teins in aqueousmediamakes essential the use of stabilizing techniques,
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most widely used strategy. However the use of detergents, even in min-
ute proportions, can perturb the results of techniques used in the study
of lipid–protein interactions. As an alternative, aMBP–SCR fusion protein
has been used in this study, with the MBP moiety bound to the amino
end of SCR, thus away from the putative TMD located at the carboxyl
end. The results are interesting because the protein is stable in
detergent-free buffers (data not shown) and yet it binds lipid mono-
layers (Fig. 3B) and bilayers (Fig. 5), something that free MBP cannot
do (Fig. 2B). MBP–SCR can be reconstituted in bilayers (Fig. 6) and be-
haves thereafter as an intrinsic protein (Fig. 7). Additionally, MBP does
not hamper scramblase activity when anchored to the SCR N-ter (data
not shown). Thus the data appear to reinforce that the C-terminal TMD
is essential for the scramblase activity.
4.5. SCR TMD and cytoplasmic domain interaction with membranes
Even when SCRΔ shows such a high afﬁnity for lipids (Figs. 3, 4
and 6), it cannot promote lipid randomization at the assayed calcium
concentrations [3,4], conﬁrming that the SCR cytoplasmic domain is
not enough for the promotion of lipid translocation. Thus the TMD
appears to be essential for the scramblase activity. Our preliminary
data (not shown) suggest that reconstituted MBP–SCR fusion protein
is able to promote similar pyrene-SM ﬂip-ﬂop as SCR, in agreement
with Zhou et al. [21], therefore the MBP anchor at the N-terminus ofSCR does not hamper SCR translocation mechanism, as long as there is
a TMD.
TMD, apart from its role as SCR anchor to the cell membrane, might
be the putative segment F of the EF-handmotif [22,23], although several
researchers disagree on this matter [10,24]. Calcium binding could
change the folding or the tilting of the protein TMD (apart from chang-
ing the tertiary structure of thewhole protein cytoplasmic domain), this
new conformation allows the membrane lipid scrambling activity. In
fact, the presence of transmembrane stretches of proteins in the bilayer
is known to be sufﬁcient to allow some degree of phospholipid ﬂip-ﬂop
in membranes [25–27]. For instance, Langer et al. [28] conﬁrmed that
peptides mimicking the α-helices of SNARE protein TMD could
stimulate lipid ﬂipping in model membranes, although they could not
promote vesicle fusion as wild type SNARE protein complexes do.
In view of the uncertainties surrounding the role of TMD in the SCR
activity, studies have been undertaken in our laboratory in which syn-
thetic TMD-mimetic peptides have been examined in the presence of
lipid bilayers [5], showing that the TMD can be inserted in lipid bilayers
of various compositions. Moreover, experiments reported here support
that the N-terminal cytoplasmic moiety of SCR is also an important
determinant for protein binding to model membranes. Thus in the cell
environment, both the SCR cytoplasmic and transmembrane domains
may feature ﬂexible and adaptive interactions with the membrane. It
should also be remembered that native SCR, but not the protein over-
expressed in bacteria used in this kind of studies, is multipalmitoylated
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protein to the cell membrane.
We conclude that the available evidence for the interaction of SCR
with membranes points to a model in which the putative TMD would
get inserted into the bilayer as in a classical monotopic protein, while
the major cytoplasmic domain would interact directly and perhaps
also through acyl chains with the membrane lipid matrix.Acknowledgements
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